Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Idera Pharmaceuticals Company Profile (NASDAQ:IDRA)

Consensus Ratings for Idera Pharmaceuticals (NASDAQ:IDRA) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $6.10 (131.06% upside)

Analysts' Ratings History for Idera Pharmaceuticals (NASDAQ:IDRA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/28/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/6/2014ZacksDowngradeNeutral$6.10ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Piper JaffrayInitiated CoverageOverweight$2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)